Maxwell engineers technologies designed to create health for the world, safely and affordably. We are currently focused on Alzheimer’s Disease, and have several candidate drugs and therapies which have proven successful in mouse studies at Stanford and are now entering human clinical trials.

Hetrochronic Optimized Plasma Exchange (H.O.P.E.) for Alzheimer’s

The patent-pending therapeutic plasma exchange protocol that uses an optimized plasma product as a new Alzheimer’s biologic drug.


With the right artificial intelligence assisted MAP (Multifactorial Analysis and Plan) together we can prevent and reverse cognitive decline and optimize brain performance.


About MaxWell Brain.


Young Donor
Plasma Registry

Health Anonymous, a division of MaxWell Biosciences, is the world’s first and largest curated, young donor plasma registry. These unknown heroes enable MaxWell to pioneer novel therapies and empower the world to act on chronic health issues.